非经典 IKK 在癌症中的新兴作用。
Emerging roles for the non-canonical IKKs in cancer.
机构信息
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA.
出版信息
Oncogene. 2011 Feb 10;30(6):631-41. doi: 10.1038/onc.2010.493. Epub 2010 Nov 1.
Abstract
The IκB Kinase (IKK)-related kinases TBK1 and IKKɛ have essential roles as regulators of innate immunity by modulating interferon and NF-κB signaling. Recent work has also implicated these non-canonical IKKs in malignant transformation. IKKɛ is amplified in ∼30% of breast cancers and transforms cells through the activation of NF-κB. TBK1 participates in RalB-mediated inflammatory responses and cell survival, and is essential for the survival of non-small cell lung cancers driven by oncogenic KRAS. The delineation of target substrates and downstream activities for TBK1 and IKKɛ has begun to define their role(s) in promoting tumorigenesis. In this review, we will highlight the mechanisms by which IKKɛ and TBK1 orchestrate pathways involved in inflammation and cancer.
摘要
IKK 相关激酶 TBK1 和 IKKɛ 通过调节干扰素和 NF-κB 信号通路，在先天免疫中发挥着重要作用。最近的研究还表明这些非经典 IKK 在恶性转化中也有作用。IKKɛ 在约 30%的乳腺癌中扩增，并通过激活 NF-κB 来转化细胞。TBK1 参与 RalB 介导的炎症反应和细胞存活，并且对于由致癌 KRAS 驱动的非小细胞肺癌的存活是必需的。TBK1 和 IKKɛ 的靶底物和下游活性的描绘已经开始定义它们在促进肿瘤发生中的作用。在这篇综述中，我们将强调 IKKɛ 和 TBK1 协调参与炎症和癌症的途径的机制。
相似文献
1
Emerging roles for the non-canonical IKKs in cancer.非经典 IKK 在癌症中的新兴作用。
Oncogene. 2011 Feb 10;30(6):631-41. doi: 10.1038/onc.2010.493. Epub 2010 Nov 1.
2
Non-canonical IKKs, IKKϵ and TBK1, as novel therapeutic targets in the treatment of non-small cell lung cancer.非经典 IKKs、IKKϵ 和 TBK1 作为治疗非小细胞肺癌的新型治疗靶点。
Expert Opin Ther Targets. 2013 Oct;17(10):1109-12. doi: 10.1517/14728222.2013.833188. Epub 2013 Aug 28.
3
Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated?IKK以及与IKK相关的激酶TBK1和IKK-ε的激活方式是否类似？
Trends Biochem Sci. 2008 Apr;33(4):171-80. doi: 10.1016/j.tibs.2008.01.002. Epub 2008 Mar 18.
4
Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B.赖氨酰氧化酶通过阻止核因子-κB的激活来抑制Ras介导的细胞转化。
Mol Cell Biol. 2003 Apr;23(7):2251-63. doi: 10.1128/MCB.23.7.2251-2263.2003.
5
The IKK-related kinases: from innate immunity to oncogenesis.与IKK相关的激酶：从固有免疫到肿瘤发生
Cell Res. 2008 Sep;18(9):889-99. doi: 10.1038/cr.2008.273.
6
Regulation and function of IKK and IKK-related kinases.IKK及IKK相关激酶的调控与功能
Sci STKE. 2006 Oct 17;2006(357):re13. doi: 10.1126/stke.3572006re13.
7
TBK1 and IKKε Act Redundantly to Mediate STING-Induced NF-κB Responses in Myeloid Cells.TBK1 和 IKKε 冗余性地介导 STING 诱导的髓系细胞中的 NF-κB 反应。
Cell Rep. 2020 Apr 7;31(1):107492. doi: 10.1016/j.celrep.2020.03.056.
8
The non-canonical IκB kinases IKKε and TBK1 as potential targets for the development of novel therapeutic drugs.非经典 IκB 激酶 IKKε 和 TBK1 作为新型治疗药物开发的潜在靶点。
Curr Mol Med. 2013 Aug;13(7):1089-97. doi: 10.2174/1566524011313070004.
9
Identification of TBK1 and IKKε, the non-canonical IκB kinases, as crucial pro-survival factors in HTLV-1-transformed T lymphocytes.鉴定TBK1和IKKε（非典型IκB激酶）为人类嗜T淋巴细胞病毒1型（HTLV-1）转化的T淋巴细胞中关键的促存活因子。
Leuk Res. 2016 Jul;46:37-44. doi: 10.1016/j.leukres.2016.04.012. Epub 2016 Apr 16.
10
IκB kinase ε (IKKε): a therapeutic target in inflammation and cancer.IKKε（IκB 激酶 ε）：炎症和癌症治疗的靶点。
Biochem Pharmacol. 2013 Apr 1;85(7):873-80. doi: 10.1016/j.bcp.2013.01.007. Epub 2013 Jan 17.
引用本文的文献
1
TANK-Binding Kinase 1 in the Pathogenesis and Treatment of Inflammation-Related Diseases.炎症相关疾病发病机制及治疗中的 Tank 结合激酶 1
Int J Mol Sci. 2025 Feb 24;26(5):1941. doi: 10.3390/ijms26051941.
2
TBK1 inhibitor amlexanox exerts anti-cancer effects against endometrial cancer by regulating AKT/NF-κB signaling.TBK1抑制剂氨来呫诺通过调节AKT/NF-κB信号通路发挥抗子宫内膜癌的作用。
Int J Biol Sci. 2025 Jan 1;21(1):143-159. doi: 10.7150/ijbs.100212. eCollection 2025.
3
The Importance of Including Maternal Immune Activation in Animal Models of Hypoxic-Ischemic Encephalopathy.在缺氧缺血性脑病动物模型中纳入母体免疫激活的重要性。
Biomedicines. 2024 Nov 8;12(11):2559. doi: 10.3390/biomedicines12112559.
4
TBK1 is paradoxical in tumor development: a focus on the pathway mediating IFN-I expression.TBK1 在肿瘤发展中具有矛盾性：聚焦于介导 IFN-I 表达的途径。
Front Immunol. 2024 Aug 5;15:1433321. doi: 10.3389/fimmu.2024.1433321. eCollection 2024.
5
MARCH1 negatively regulates TBK1-mTOR signaling pathway by ubiquitinating TBK1.MARCH1 通过泛素化 TBK1 负调控 TBK1-mTOR 信号通路。
BMC Cancer. 2024 Jul 26;24(1):902. doi: 10.1186/s12885-024-12667-y.
6
Statin prevents cancer development in chronic inflammation by blocking interleukin 33 expression.他汀类药物通过阻断白细胞介素 33 的表达来预防慢性炎症中的癌症发展。
Nat Commun. 2024 May 30;15(1):4099. doi: 10.1038/s41467-024-48441-8.
7
Impact of modeled microgravity stress on innate immunity in a beneficial animal-microbe symbiosis.模拟微重力应激对有益动物-微生物共生中先天免疫的影响。
Sci Rep. 2024 Feb 5;14(1):2912. doi: 10.1038/s41598-024-53477-3.
8
Anoikis resistance--protagonists of breast cancer cells survive and metastasize after ECM detachment.失巢凋亡抵抗——细胞外基质解离后乳腺癌细胞存活和转移的主角。
Cell Commun Signal. 2023 Aug 3;21(1):190. doi: 10.1186/s12964-023-01183-4.
9
Frustration analysis of TBK1 missense mutations reported in ALS/FTD and cancer patients.对肌萎缩侧索硬化症/额颞叶痴呆（ALS/FTD）患者和癌症患者中报告的TBK1错义突变的功能丧失分析
3 Biotech. 2022 Aug;12(8):174. doi: 10.1007/s13205-022-03240-0. Epub 2022 Jul 14.
10
Role of IKKε in the Metabolic Diseases: Physiology, Pathophysiology, and Pharmacology.IKKε在代谢性疾病中的作用：生理学、病理生理学及药理学
Front Pharmacol. 2022 May 19;13:888588. doi: 10.3389/fphar.2022.888588. eCollection 2022.
本文引用的文献
1
Diverse somatic mutation patterns and pathway alterations in human cancers.人类癌症中的多种体细胞突变模式和通路改变。
Nature. 2010 Aug 12;466(7308):869-73. doi: 10.1038/nature09208. Epub 2010 Jul 28.
2
Specification of the NF-kappaB transcriptional response by p65 phosphorylation and TNF-induced nuclear translocation of IKK epsilon.p65 磷酸化特异性调节 NF-κB 的转录反应和 TNF 诱导的 IKKε 核转位。
Nucleic Acids Res. 2010 Oct;38(18):6029-44. doi: 10.1093/nar/gkq439. Epub 2010 May 27.
3
NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways.NLRC5 负调控 NF-κB 和 I 型干扰素信号通路。
Cell. 2010 Apr 30;141(3):483-96. doi: 10.1016/j.cell.2010.03.040.
4
Requirement of the NF-kappaB subunit p65/RelA for K-Ras-induced lung tumorigenesis.NF-κB 亚基 p65/RelA 对 K-Ras 诱导的肺肿瘤发生的要求。
Cancer Res. 2010 May 1;70(9):3537-46. doi: 10.1158/0008-5472.CAN-09-4290. Epub 2010 Apr 20.
5
TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases.TAX1BP1 和 A20 通过靶向 TBK1-IKKi 激酶抑制抗病毒信号。
J Biol Chem. 2010 May 14;285(20):14999-15009. doi: 10.1074/jbc.M110.109819. Epub 2010 Mar 19.
6
SUMOylation-dependent localization of IKKepsilon in PML nuclear bodies is essential for protection against DNA-damage-triggered cell death.SUMOylation 依赖性的 IKKepsilon 在 PML 核小体中的定位对于防止 DNA 损伤触发的细胞死亡至关重要。
Mol Cell. 2010 Feb 26;37(4):503-15. doi: 10.1016/j.molcel.2010.01.018.
7
The landscape of somatic copy-number alteration across human cancers.人类癌症中体细胞拷贝数改变的全景。
Nature. 2010 Feb 18;463(7283):899-905. doi: 10.1038/nature08822.
8
Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression.饮食和遗传肥胖通过增强 IL-6 和 TNF 的表达促进肝脏炎症和肿瘤发生。
Cell. 2010 Jan 22;140(2):197-208. doi: 10.1016/j.cell.2009.12.052.
9
Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB Pathway.癌蛋白 Bmi-1 通过激活 IKK-核因子-κB 通路使神经胶质瘤细胞产生抗凋亡作用。
Am J Pathol. 2010 Feb;176(2):699-709. doi: 10.2353/ajpath.2010.090502. Epub 2009 Dec 24.
10
IKKepsilon phosphorylation of estrogen receptor alpha Ser-167 and contribution to tamoxifen resistance in breast cancer.IKKepsilon 对雌激素受体 α Ser-167 的磷酸化作用及其在乳腺癌中对他莫昔芬耐药性的贡献。
J Biol Chem. 2010 Feb 5;285(6):3676-3684. doi: 10.1074/jbc.M109.078212. Epub 2009 Nov 23.
Zotero 插件